Webinar: Thursday, May 21, 2020
10:00 am or 4:00 pm Eastern Daylight Time
Presented by Dr. Baozhen Shan, PhD, CEO.
As governments begin to ease social and economic restrictions, the development for effective therapeutic treatments has become the next critical hurdle in the fight against the COVID-19 global pandemic. Since the outbreak of the SARS-CoV-2, a growing number of companies, labs and researchers have shifted their focus and resources to offset this virus, with new results and publications reported daily. Fortunately with the technology available today, we are able to work together to share these results with one another and pool our resources to speed up the road to recovery. With our experience and tools for mass spectrometry-based proteomics, we hope to work together and contribute in our way against the outbreak of SARS-CoV-2.
On Thursday, May 21st, join us as we look at how mass spectrometry-based proteomics can play a role in developing antibodies and biotherapeutics to fight against COVID-19, and the efforts made by Bioinformatics Solutions Inc.
- Mass spectrometry experiment design
- Combination of bottom-up, top-down and middle-down mass spectrometry
- Spike protein enrichment
- Antibody purification
- Data Analysis
- Screening of spike protein enrichment
- De novo sequencing of antibodies
- Glycan analysis